Christine Shieh, MD
Ophthalmology · Nashville, TNNPI 1053631705
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $7,869 of the $10,011 with a category attached, or 78.6%. GSK accounts for 87.2% of it on its own, with 4 other manufacturers making up the rest. Reporting peaked in 2019 at $7,225 and has fallen 97.6% since, to $175 in 2024. Among ophthalmology clinicians in TN with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 19 payments — averaging $526.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$9K
- Johnson & Johnson Surgical Vision, Inc.$1K
- Dompe US, Inc.$139
- Carl Zeiss Meditec, Inc.$36
- Omeros Corporation$11
What the payments were for
- Consulting fees$7,86979%
- Travel & lodging$1,44014%
- Food & beverage$7027%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 11 | $8,732 |
| Johnson & Johnson Surgical Vision, Inc. | 5 | $1,093 |
| Dompe US, Inc. | 1 | $139 |
| Carl Zeiss Meditec, Inc. | 1 | $36 |
| Omeros Corporation | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$10,011 in reported general payments places this provider in the 90th percentile of 323 ophthalmology providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MieboPerfluorohexyloctane/Pf | 79 | $73,975 |
| RestasisCyclosporine | 32 | $32,329 |
| XiidraLifitegrast | 19 | $17,163 |
| Cyclosporine | 16 | $13,031 |
| Prednisolone Acetate | 247 | $11,299 |
| Restasis MultidoseCyclosporine | 12 | $11,211 |
| ZirganGanciclovir | 20 | $11,152 |
| TyrvayaVarenicline Tartrate | 13 | $8,541 |
| IlevroNepafenac | 18 | $6,548 |
| MoxifloxacinMoxifloxacin Hcl | 221 | $5,158 |
| Fluorometholone | 29 | $3,012 |
| Loteprednol Etabonate | 13 | $1,977 |
| ValacyclovirValacyclovir Hcl | 23 | $1,482 |
| Ketorolac Tromethamine | 75 | $1,385 |
| Tobramycin-DexamethasoneTobramycin/Dexamethasone | 28 | $1,102 |
Paid to pharmacies, not to this prescriber.
Other ophthalmology in Nashville
- Deborah ShermanNashville$3M
- Brian BiesmanNashville$630K
- Edward ChaumNashville$158K
- Jeffrey HornNashville$106K
- Avni FinnNashville$57K
- Louise MawnNashville$56K
- Jeffrey KammerNashville$30K
- Gary JerkinsNashville$15K
- Allison SmithNashville$13K
- Ira ShivitzNashville$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.